P3 Health Partners PE Ratio 2020-2025 | PIII

Current and historical p/e ratio for P3 Health Partners (PIII) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. P3 Health Partners PE ratio as of June 06, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

P3 Health Partners PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-06 6.62 0.00
2025-03-31 8.21 $-47.28 0.00
2024-12-31 11.25 $-49.00 0.00
2024-09-30 19.32 $-42.00 0.00
2024-06-30 22.52 $-32.50 0.00
2024-03-31 51.50 $-29.50 0.00
2023-12-31 70.50 $-32.50 0.00
2023-09-30 73.50 $-113,033.00 0.00
2023-06-30 149.50 $-113,040.50 0.00
2023-03-31 53.00 $-113,036.00 0.00
2022-12-31 92.00 $-113,025.00 0.00
2022-09-30 231.00 $-13.50 0.00
2022-06-30 186.00 0 0.00
2022-03-31 391.00 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.047B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.172B 60.28
Hims & Hers Health (HIMS) United States $11.812B 122.72
Tempus AI (TEM) United States $10.155B 0.00
IRhythm Technologies (IRTC) United States $4.637B 0.00
Inspire Medical Systems (INSP) United States $4.007B 62.61
Hinge Health (HNGE) United States $3.004B 0.00
Privia Health (PRVA) United States $2.780B 190.00
Enovis (ENOV) United States $1.805B 10.06
Schrodinger (SDGR) United States $1.749B 0.00
Clover Health Investments (CLOV) United States $1.537B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.446B 25.51
Azenta (AZTA) United States $1.296B 60.21
10x Genomics (TXG) United States $1.122B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Claritev (CTEV) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.544B 162.50
Veradigm (MDRX) United States $0.487B 0.00
Standard BioTools (LAB) United States $0.378B 0.00
Outset Medical (OM) United States $0.356B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Health Catalyst (HCAT) United States $0.267B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
Pulmonx (LUNG) United States $0.120B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.072B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00